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Abstract 
Background: This last decade, a lot of emphasis has been placed on developing new cancer cell culture models, 
closer to in vivo condition, in order to test new drugs and therapies. In the case of colorectal cancer, the use of patient 
biopsies to seed 3D primary cultures and mimic tumor initiation necessitates the use of antibiotics to prevent micro‑
bial intestinal contamination. However, not only long term use of antibiotics may mask the presence of low levels of 
microbial contamination, it may also impact cancer cell phenotype.
Methods: In this study we tested the impact of penicillin‑streptomycin cocktail addition in both monolayer and sus‑
pension culture. To ensure the reliability of our observations we used six different cell lines and each experiment was 
performed in triplicate. Results were analyzed with Student’s t test.
Results: We show that penicillin–streptomycin cocktail inhibits the sphere‑forming ability of six cancer cell lines in 
suspension culture though it has no impact in monolayer culture. We correlate this effect with a significant decrease 
of cancer stem cells pool which holds self‑renewal potential.
Conclusions: Overall, this study warns against systematic addition of antibiotics in growth medium and raises the 
interesting possibility of using antibiotics to target cancer stem cells.
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Background
Despite significant advances in diagnostics and therapeu-
tic treatment, colorectal cancer (CRC) remains a major 
cause of mortality worldwide [1]. This is due to the fact 
that CRC survival is highly dependent upon stage of dis-
ease at diagnosis: though early stage show 70–90 % 5-year 
survival, once the tumor spreads out to distant organs, 
5-year survival plummets toward 10  % [2]. Therefore, 
there is a real need for a better understanding of molecu-
lar and cellular events triggering metastatic process and 
the conception of new, adapted, therapeutic strategies. 
This need led to the development of suspension culture 
systems, such as tumorsphere formation assay, mirroring 
in vivo tumor initiation and heterogeneity. The growth of 
microtumor-like spheroids in non-adherent culture and 
serum free conditions [3] necessitates the acquisition of 
“cancer stem cell phenotype” which lends self-renewal, 
multipotency, chemoresistance, and metastatic prop-
erties [4]. In the case of CRC, this cell culture model is 
often used as a surrogate to evaluate tumorigenic poten-
tial [5].
Antibiotics are often used in cell culture in order to 
prevent contamination with microbiological organism. 
However, this practice remains controversial since the 
routine use of antibiotics may favor the development of 
resistant strains and cryptogenic contaminants such as 
mycoplasmae or viruses. Penicillin–streptomycin (P/S) 
cocktail is the only one “recommended” by American 
Type Culture Collection (ATCC), though this biore-
source center avoids using any antibiotic for routine cell 
culture and warns again long-term usage of it. While the 
use of this antimicrobial combination in regular culture 
Open Access
Cancer Cell International
*Correspondence:  fmacari@igf.cnrs.fr; adavid@igf.cnrs.fr 
†Sébastien Relier, Laura Yazdani and Oualid Ayad are co‑first authors 
††Françoise Macari and Alexandre David are co‑last authors
1 CNRS, UMR‑5203, Institut de Génomique Fonctionnelle, 
34094 Montpellier, France
Full list of author information is available at the end of the article
Page 2 of 9Relier et al. Cancer Cell Int  (2016) 16:6 
condition is dispensable, it becomes a prerequisite when 
trying to establish cell line from colorectal tumor biop-
sies, heavily contaminated with microorganisms. The 
effect of P/S addition in three-dimensional (3D) cultures 
of cancer cells has never been addressed while several 
publications have raised concerns regarding the use of 
antibiotics, especially in serum-free conditions [6–15]. 
In order to improve sphere culture conditions—that 
favors cancer stem cell survival and growth—we tested 
the impact of antibiotics on suspension culture. We show 
that P/S addition triggers a striking decrease of sphere 
formation in six cancer cell lines from three distinct tis-
sue origins. The magnitude of this effect is proportional 
to P/S concentration and correlates with reduced cancer 
stem cell population.
Results
In order to establish a broad picture of P/S effects on 
CRC cell growth, we chose four different cell lines: 
HT29, a colon adenocarcinoma grade II cell line; T84, a 
cell line derived from a lung metastasis of a colon carci-
noma; CRC-1, a cell line derived in our lab from freshly 
isolated colorectal adenocarcinoma, CPP19, another 
cell line derived in our lab from hepatic metastasis of a 
CRC patient. Each of these cell lines was grown in mon-
olayer culture for 2 weeks minimum, in the presence or 
absence of antibiotics, before being tested (Fig. 1). First, 
we tested the impact of P/S on cell growth in classical 
adherent conditions. Cell number was counted, in the 
presence or absence of antibiotics on a daily basis for 
4  days (Fig.  2a). P/S slightly increased cell proliferation 
in HT29 and T84 cells, but had no effect in CRC-1 and 
CPP19 cells, underlining a subtle but noteworthy differ-
ential effect according to tumor cell origin. Accordingly, 
P/S addition did not impact cell cycle (Fig. 2b). Then, we 
tested the effect of antibiotic addition on cell suspension 
culture. Unlike monolayer condition, suspension cul-
ture favors the growth of tumor cells that possess sphere 
forming ability in serum-free medium at low cell density. 
Remarkably, suspension culture was severely impacted 
by P/S addition that triggered about fivefold decrease in 
sphere formation (Fig. 3a). This effect did not depend on 
the nature of cell lines and patient stage since the four 
cell lines tested were sensitive to a similar extend. Fur-
thermore, inhibition of sphere forming ability correlates 
nicely with increasing concentrations of P/S and illus-
trates a typical dose-response relationship (Fig.  3b). In 
order to test whether this observation could be extended 
to other cancer types, we tested two other cell lines: 
A549, a lung epithelial carcinoma, and MCF7, a cell line 
derived from a pleural metastasis of breast adenocarci-
noma. As expected, while P/S addition did not impact 
cell proliferation in monolayer culture (Fig.  4a), it trig-
gered a significant inhibition of sphere forming efficiency 
in both MCF7 and A549 cell lines (Fig. 4b). In both T84 
and CPP19 cells, decreased sphere forming potential in 
the presence of P/S correlated with elevated cell apop-
tosis (Fig. 5a). Depending upon the cellular context, cell 
cycle disturbance may trigger apoptosis [16]. However 
P/S addition did not seem to impact cell cycle, as shown 
by propidium iodide staining (Fig.  5b). This last obser-
vation—combined with the fact that antibiotics do not 
affect cell proliferation in monolayer culture- led us to 
think that P/S may not have a broad effect, but instead 
a selective one, impacting specific cell sub-population(s). 
Spheres forming ability in suspension culture is a proxy 
for in  vivo tumorigenesis and relies on tumor initiating 
cells (TIC) proportion in the cell line. TIC, also called 
“cancer stem cells”, drive tumorigenic process through 
their self-renewal ability and their “plasticity” that per-
mits to give rise to all cell types found in a particular 
tumor sample [17]. Though there is no ideal membrane 
marker for TIC, a growing number of studies have shown 
that high aldehyde dehydrogenase (ALDH) enzyme activ-
ity is associated with enhanced self-renewal capacity and 
in  vivo tumorigenicity [18], both hallmarks of TIC. In 
T84 and CPP19 cells cultured in suspension condition, 
P/S addition triggered a significant decrease of ALDH 
positive cells (Fig.  5c) which is consistent with reduced 
sphere number (Fig.  3a). Therefore, P/S effect on cell 
suspension culture could well arise from specific impair-
ment of self-renewal ability which is indispensable for 
TIC survival.    
Discussion
The goal of this study was to evaluate the impact of P/S 
addition on 3D culture of cancer cell lines. We focused 
our attention on commonly used combination of penicil-
lin and streptomycin. By opposition with previous stud-
ies [19], P/S addition did not impact cell proliferation in 
regular growth condition for any of the cell lines tested. 
However, this study revealed a severe decrease of sphere Fig. 1 Schematic representation of the experimental protocol
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number following P/S addition. As suggested by ALDH 
labeling experiments, this effect might result from a spe-
cific decrease of TIC population which nucleates sphere 
formation. We speculate that the loss of TIC phenotype 
triggers cell apoptosis, perhaps through resensitization to 
anoikis [20]. Altogether, this study warns against system-
atic addition of antibiotics in growth medium, especially 
in suspension culture where their usage is counter-pro-
ductive and prone to artifacts.
Preventing contamination is a constant challenge in 
cell culture that needs to be addressed with caution. 
Sole reliance on antibiotics leads to poor aseptic tech-
niques, increased mycoplasma contamination, increased 
antibiotic resistance among contaminants, and—as 
Fig. 2 Effect of P/S on cell proliferation and cell cycle. a Cell proliferation was analyzed in the presence or not of antibiotics. Results are the 
mean ± SEM of triplicate and representative of four separate experiments. b Cell cycle was analyzed by flow cytometry on T84 and CPP19 cell lines. 
Results are the mean ± SEM of three separate experiments
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Fig. 3 Impact of P/S addition on suspension culture. a T84, HT‑29, CRC1 and CPP19 cell lines were passaged in suspension culture and tested for 
their ability to form spheres. Tukey boxplots that represent the first and the third quartiles by the upper and lower horizontal lines in a rectangular box, 
inside of which the horizontal line represents the median. ***p < 0.001, two tailed unpaired t test; Values are representative of three experiments. 
Pictures show representative field. Scale bar 100 µm. b Dose–response effects of P/S on sphere forming ability of T84 cell line in suspension culture. 
Results are representative of three distinct experiments
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exemplified in this study—experimental bias. Therefore, 
what other alternative to P/S addition might there be to 
prevent growth medium contamination? From a practi-
cal standpoint, most general cell culture can be usually 
done in the absence of antibiotics, though it requires a 
basic culture management, tailored to meet the specific 
needs of the laboratory’s working conditions. Achieving 
and maintaining good aseptic technique is key, espe-
cially when working with valuable cultures. Neverthe-
less, under some circumstances—such as cell isolation 
of human biopsy—a decontamination procedure cannot 
be avoided. In any event, antibiotics should only be used 
as a last resort for short term applications, and they 
should be removed from the culture as soon as possi-
ble. Finally, we recommend caution in using antibiotics 
from aminoglycoside family (e.g., streptomycin, genta-
mycin, kanamycin) whose intrinsic RNA-binding prop-
erties may impact gene expression and cell properties. 
Halving the concentration of antibiotics is an accept-
able possibility to consider: as shown in this study, the 
recommended working concentration of streptomycin 
ranges from 30 to 100 µg/mL which translates into sig-
nificant differences in term of sphere forming ability 
(Fig. 3b).
Fig. 4 Effect of P/S on other cancer types. a Cell proliferation analysis of MCF7 and A549 cell lines in the presence or not of antibiotics. Results are 
the mean ± SEM of triplicate and representative of three separate experiments. b Ability of MCF7 and A549 cell lines to form sphere in suspension 
culture. Tukey boxplots as in Fig. 3. Values are representative of three experiments. ***p < 0.001, two‑tailed unpaired t test. Pictures show representa‑
tive field. Scale bar 100 µm
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Fig. 5 P/S addition does not affect cell cycle but targets ALDH + cells. Cell death (a) and cell cycle (b) were evaluated by flow cytometry analysis 
on T84 and CPP19 cell lines cultured in suspension condition. Results are the mean ± SEM of triplicate and representative of three separate experi‑
ments. c ALDH enzyme activity in T84 and CPP19 cell lines grown in suspension culture was analyzed by flow cytometry. As a negative control, cells 
were treated with the specific ALDH inhibitor DEAB. The gated cells represent the ALDH positive cells
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From a functional perspective, we envision three possi-
bilities in which streptomycin plays a pivotal role by asso-
ciating with RNA structure(s).
First, while streptomycin specifically targets 30S 
prokaryotic ribosomal subunit, it can also associate with 
eukaryotic ribosomes when certain structural conditions 
are met [21–23]. By analyzing polysome profile from 
monolayers cultures of T84 cells, we did not observe any 
quantitative effect on global protein synthesis following 
P/S addition (Fig.  6). However, it does not discard the 
possibility of a subtle and “qualitative” change, which 
may impact a minor population of streptomycin-sensitive 
ribosomes.
Second, streptomycin could affect mitochondrial trans-
lation and most particularly that of TIC. This view is in 
line with a recent report suggesting that antibiotics tar-
geting prokaryotic ribosome specifically impact mito-
chondrial activity in cancer stem cells and trigger cell 
death [24]. Nevertheless, it does not explain why mito-
chondrial activity is not impacted in monolayer culture, 
where high proliferation necessitates elevated protein 
synthesis rate, one of the most energy consuming pro-
cesses in the cell.
Finally, streptomycin could associate with certain RNA 
hairpin loops and interfere with RNA processing/func-
tion. Indeed, while aminoglycosides are mainly used as 
therapeutic agents to target bacteria, they can bind in a 
non-selective manner to a variety of RNA that possess 
characteristic stem-loop structures, such as viral or non-
coding RNA [25, 26]. A recent study raises the inter-
esting possibility that aminoglycosides could bind to 
oncogenic miRNA precursors—that possess stem-loop 
structure—and inhibit their processing into fully func-
tional miRNA [27]. This hypothesis is plausible given the 
complexity of cancer cell [28] and the great importance 
of miRNA networks in the regulation of TIC properties 
[20, 29].
Conclusions
Overall, this study warns against routine usage of antibi-
otics whose “off-target” effects—hitherto poorly under-
stood—may bias experimental results. While the precise 
mechanism by which P/S inhibits sphere-forming ability 
remains to be elucidated, it moots the exciting possibility 
of using antibiotics as tools for anti-TIC therapies. This 
idea is particularly attractive when considering that many 
antibiotics are already FDA approved.
Methods
Cells and ethics statement
Patient-derived cell culture of colon cancer cells (CRC-1 
and CPP19) were obtained from CRC biopsies provided 
by CHU-Carémeau (Nîmes, France) within an approved 
protocol (ethical agreement no 2011-A01141-40). Signed 
informed consents were obtained from patients prior 
to samples acquisition in accordance with all ethical 
and legal aspects. The «Agence nationale de sécurité du 
médicament et des produits de santé » (ANSM) reviewed 
and approved this study.
Tumors were washed, minced into fragments 
(<2 mm3), digested with 0.26 U/ml of liberase H (Roche), 
and resuspended in Accumax (Sigma-Aldrich). Following 
2 h at 37 °C, cell suspension was filtered through a 40 mm 
mesh and plated in DMEM medium (Invitrogen), sup-
plemented with 10  % fetal calf serum (FCS), glutamine, 
antibiotics (P/S) and non-essential aminoacids. When a 
monolayer of patient-derived tumour cells was formed, 
cells were detached using trypsin/EDTA and resus-
pended in DMEM with 10 % FCS.
T84 and HT-29 cells were purchased from American 
Type Culture Collection (ATCC).
Cell culture and cell proliferation
T84, HT-29 CRC-1, CPP19, A549 and MCF7 cell lines 
were cultured at 37  °C under humidified 5  % CO2 in 
DMEM medium (Invitrogen) or RPMI (Invitrogen, for 
MCF7 and A549) supplemented with 10  % fetal calf 
serum (Invitrogen), 2  mM glutamine, with or without 
antibiotics: 100 μg/ml streptomycin and 100 U/ml peni-
cillin (Invitrogen). For cell proliferation analyses, 5 × 105 
cells were cultured in triplicate in a 12 well plate for 24, 
48, 72 or 96  h. Cells were then resuspended in DMEM 
with 10  % FCS, after Trypsine—EDTA treatment, for 
counting.
Fig. 6 Polysome profiles from T84 monolayers grown with or without 
P/S. Briefly, cell lyzates were fractionated on 15–50 % sucrose gradient 
to isolate polysomes. Absorbance profile was continuously measured 
at 254 nm
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Sphere formation assays
Number of Cell Forming Sphere were determined after 
plating of 1000 cells/ml M11 medium (DMEM/F12 (1:1) 
Glutamax medium, N2 Supplement, Glucose 0.3 %, insu-
lin 20 µg/ml, hBasic-FGF 10 ng/ml, hEGF 20 ng/ml), with 
or without antibiotics (Penicillin G 100 U/ml, Streptomy-
cin 100  µg/ml) in ultra-low attachment p24-well plates 
(11 wells/condition) (Corning). Spheres >50 µm diameter 
were counted after 6 days.
Polysome profiling
Cells (4 ×  106) were treated with 20  µg/ml emetine for 
15  min at 37  °C, washed twice with ice-cold PBS/CHX, 
and scraped. Cells were homogenized by hard shaking 
with 1.4  mm ceramix spheres (Lysing matrix D MPbio) 
in FastPrep machine, loaded on 15–50 % sucrose gradi-
ent and polysome were fractionated [30]. Fractions were 
collected with an ISCO (Lincoln, NE) density gradient 
fractionation system. The settings were as follows: pump 
speed 0.7  ml/min, fraction time 1  min/fraction, chart 
speed 150 cm/h and sensitivity of OD254 recorder to 1. 
The absorbance at 254 nm was measured continuously as 
a function of gradient depth.
Cell cycle
Cell pellets (5  ×  105 cells) were incubated 1  h on ice 
before staining overnight at 4  °C with 500 µl of propid-
ium iodide solution (25 µg/ml of propidium iodide, 0.1 % 
of Triton X100 and 0.1 % of Trisodium citrate dihydrate 
in water). Analysis was performed by flow cytometry 
(MACSQuant Analyzer, Miltenyi Biotec).
Apoptose analysis
Cells (5  ×  105) were stained with 125  ng of annexin 
V-FluoProbes 488 (Interchim) and 7-AAD (1  μg/ml) or 
Sytox blue (0.1 µg/ml). Cells were incubated for 15 min at 
RT and analyzed by flow cytometry (MACSQuant Ana-
lyzer, Miltenyi Biotec).
ALDEFLUOR assay
The ALDH enzymatic activity of the cells was measured 
using the ALDEFLUOR kit (Stem Cell Technologies), 
according to the manufacturer’s instructions. Briefly, 
5  ×  105 cells were suspended in ALDEFLUOR assay 
buffer containing ALDH substrate and incubated for 
30 min at 37 °C. As a reference control, cells were stained 
under identical conditions with the specific ALDH inhib-
itor diethylaminobenzaldehyde (DEAB). The brightly 
fluorescent ALDH-expressing cells were detected using 
a MACSQuant Analyzer, (Miltenyi Biotec). To exclude 
nonviable cells, Sytox blue was added at a concentration 
of 0.1 µg/ml.
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